Jake Kelly MD
814 posts

Jake Kelly MD
@jakekellymd
Performance Cardiologist | VO₂ Max, Metabolic Health & Longevity Strategist | Ironman Triathlete | Father of 3 |

DXA substudies show most GLP-1s lose lean mass at roughly the same ratio as calorie restriction alone. Tirzepatide: 26%. Diet-only benchmark: ~25%. Semaglutide is the outlier at 35-40% depending on the dataset. GLP-1s produce more total weight loss, so absolute lean loss is higher. But the proportion is largely the same. Note: DXA "lean mass" includes water and organ tissue, not just muscle. All trials included lifestyle counseling but none required resistance training or set protein targets. A case series of patients who added lifting and prioritized protein saw dramatically less lean loss, with two of three actually gaining lean mass. Heymsfield 2014 | Wilding NEJM 2021 | Look et al. 2025 | Tinsley & Nadolsky 2025







🚨New Substack Article: VO₂max vs Lactate VO₂max represents cardiorespiratory adaptations and measures oxygen delivery. Lactate reflects cellular and mitochondrial adaptations key for metabolic health. Over the past decades, elite sport moved beyond VO₂max and focused on metabolism. That shift changed how we interpret physiology, how we train and how we define performance Longevity and metabolic health are now arriving at the same crossroads. Because improving how we deliver oxygen is only part of the equation. Understanding how our cells use it is what ultimately determines metabolic health 👇 inigosanmillan.substack.com/p/vomax-vs-lac…











A stable training response comes from a stable life.










